07. August 2016 · Comments Off on Fox Chase Cancer Center & GCRF · Categories: Uncategorized

This video highlights advances in research and treatment for Gastrointestinal Stromal Tumors made at Fox Chase Cancer Center in Philadelphia. Fox Chase is grateful to the GIST Cancer Research Fund and its founders, Tania and Robert Stutman, for their generous support. In the video, Martin Belinkey, PhD, Staff Scientist, Lori Rink, PhD, Assistant Professor and Margaret von Mehren, MD, Dept. of Hematology/Oncology share some of the advances made over the past year, as well as what they will pursue in the coming year with this financial support.

The research studies by Martin Belinkey and Lori Rink can be found in the links below:

Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case

Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic effects in Preclinical Study of Gastrointestinal Stromal Tumor

Comments closed.